IMUNA PHARM, a.s.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 10 600 984 €.
Low confidence: the amount exceeds the retained earnings from which dividends can be distributed — probably a merger, an opening balance adjustment or an error in the financial statements.
Summary: IMUNA PHARM, a.s.
What kind of company is it?
IMUNA PHARM, a.s. (IČO 36473685) is a joint-stock company (a.s.). The company was incorporated in 2001 and has existed for 25 years. Registered office according to the register: Šarišské Michaľany. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 150–199 employees.
Who runs the company and who owns it?
The company has one statutory representative. The supervisory board has 1 members. The registered capital is 13 122 299 €.
How is the company doing financially?
Revenue for 2025 was 18 273 393 €, up 153 % on the previous year (7 223 053 €). From 2020 to 2025, revenue grew by an average of 5,5 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 2 322 630 € (12,7 % of revenue). The company was profitable in 1 of the 6 reported years. Personnel costs for 2025 were 3 331 777 €.
What should you look out for?
Equity was negative at the end of 2025 (-8 062 172 €).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 11. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 12 289 604 | 12 472 053 | 6 077 377 | 7 223 053 | 18 273 393 |
| Profit for the reporting year | -1 063 675 | -1 749 913 | -2 745 729 | -2 886 296 | 2 322 630 |
| Retained earnings of previous periods | -4 632 216 | -5 695 892 | -7 545 806 | -10 291 533 | -23 799 743 |
| Total assets | 47 910 089 | 44 846 528 | 40 909 554 | 39 224 640 | 15 696 054 |
| Total liabilities | 35 917 774 | 34 604 122 | 33 512 879 | 34 714 262 | 23 277 126 |
| Total equity | 7 698 120 | 5 948 206 | 3 102 477 | 216 182 | -8 062 172 |
| Calculated dividends | 0 | 0 | 100 000 | 0 | 10 600 984 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
- PHARMAGAL - BIO, spol. s r.o. · Nitra
- BIOM-R, s. r. o. · Bratislava
- Pharma Products, s.r.o. · Banská Bystrica
- INSTITUTE EUROPHARM, s.r.o. · Kežmarok
- Farmácia Martin a.s. · Martin
- International Probiotic Company s.r.o. · Košice-Staré Mesto
- MediPharm a.s. · Lipany
- Saneca Pharmaceuticals a. s. · Hlohovec
- MEDE s. r. o. · Lehnice
- BIOMIN, a.s. · Cífer